Greenfield, Edward A
Dana-Farber Cancer Institute
4 papers on CoChat
Most cited papers
- Verified
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 2,955
- Verified
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production
Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 968
- Verified
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 394
- Verified
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells
Eppihimer, M., Gunn, J., Freeman, G., Greenfield, E., Chernova, T., Erickson, J., & Leonard, J. (2002) · Microcirculation
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 272
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free